Association between biomarkers of tissue inflammation and progression of osteoarthritis: Evidence from the Rotterdam study cohort

Arthritis Research and Therapy

Volumn 18, Issue 1, 2016, Pages

  Hosnijeh, Fatemeh Saberi ^a   Siebuhr, Anne Sofie ^b   Uitterlinden, Andre G ^a   Oei, Edwin H G ^a   Hofman, Albert ^a   Karsdal, Morten A ^b   Bierma Zeinstra, Sita M ^a   Bay Jensen, Anne C ^b   van Meurs, Joyce B J ^a  

^a ERASMUS MEDICAL CENTER   (Netherlands)

^b NORDIC BIOSCIENCE A S   (Denmark)

Author keywords

Biomarker; CRP; Inflammation; Osteoarthritis; Prospective cohort

Indexed keywords

C REACTIVE PROTEIN; CARTILAGE OLIGOMERIC MATRIX PROTEIN; COLLAGEN TYPE 1; COLLAGEN TYPE 2; MATRIX METALLOPROTEINASE; BIOLOGICAL MARKER; C-TERMINAL CROSS-LINKING TELOPEPTIDE OF TYPE II COLLAGEN, HUMAN; COMP PROTEIN, HUMAN; PEPTIDE FRAGMENT;

ADULT; AGE; AGED; ARTICLE; BODY MASS; C REACTIVE PROTEIN BLOOD LEVEL; CARTILAGE OLIGOMERIC MATRIX PROTEIN BLOOD LEVEL; COHORT ANALYSIS; COLLAGEN TYPE 1 BLOOD LEVEL; COLLAGEN TYPE 2 BLOOD LEVEL; COLLAGEN TYPE 2 URINE LEVEL; CONTROLLED STUDY; DIET RESTRICTION; DISEASE ASSOCIATION; DISEASE CLASSIFICATION; DISEASE COURSE; DISEASE MARKER; EVIDENCE BASED MEDICINE; FEMALE; HIP OSTEOARTHRITIS; HUMAN; INCIDENCE; JOINT RADIOGRAPHY; KNEE OSTEOARTHRITIS; MAJOR CLINICAL STUDY; MALE; PREDICTIVE VALUE; PROGNOSIS; PROSPECTIVE STUDY; PROTEIN BLOOD LEVEL; PROTEIN DEGRADATION; PROTEIN METABOLISM; PROTEIN URINE LEVEL; SEX; BLOOD; ENZYME LINKED IMMUNOSORBENT ASSAY; IMMUNOLOGY; INFLAMMATION; METABOLISM; MIDDLE AGED; OSTEOARTHRITIS; PATHOLOGY;

AGED; BIOMARKERS; C-REACTIVE PROTEIN; CARTILAGE OLIGOMERIC MATRIX PROTEIN; COHORT STUDIES; COLLAGEN TYPE II; DISEASE PROGRESSION; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMANS; INFLAMMATION; MALE; MIDDLE AGED; OSTEOARTHRITIS; PEPTIDE FRAGMENTS; PROGNOSIS;

EID: 85008608215     PISSN: 14786354     EISSN: 14786362     Source Type: Journal    
DOI: 10.1186/S13075-016-0976-3     Document Type: Article

References (41)

1. Issa S, Sharma L. Epidemiology of osteoarthritis: An update. Curr Rheumatol Rep. 2006;8:7-15.
2. Masuko K, Murata M, Suematsu N, Okamoto K, Yudoh K, Nakamura H, et al. A metabolic aspect of osteoarthritis: lipid as a possible contributor to the pathogenesis of cartilage degradation. Clin Exp Rheumatol. 2009;27:347-53.
3. Hedbom E, Häuselmann HJ. Molecular aspects of pathogenesis in osteoarthritis: the role of inflammation. Cell Mol Life Sci. 2002;59:45-53.
4. Garnero P, Piperno M, Gineyts E, Christgau S, Delmas PD, Vignon E. Cross sectional evaluation of biochemical markers of bone, cartilage, and synovial tissue metabolism in patients with knee osteoarthritis: relations with disease activity and joint damage. Ann Rheum Dis. 2001;60:619-26.
5. Garnero P, Conrozier T, Christgau S, Mathieu P, Delmas PD, Vignon E. Urinary type II collagen C-telopeptide levels are increased in patients with rapidly destructive hip osteoarthritis. Ann Rheum Dis. 2003;62:939-43.
6. Garnero P, Ayral X, Rousseau JC, Christgau S, Sandell LJ, Dougados M, et al. Uncoupling of type II collagen synthesis and degradation predicts progression of joint damage in patients with knee osteoarthritis. Arthritis Rheum. 2002;46:2613-24.
7. Reijman M, Hazes JMW, Bierma-Zeinstra SMA, Koes BW, Christgau S, Christiansen C, et al. A new marker for osteoarthritis: cross-sectional and longitudinal approach. Arthritis Rheum. 2004;50:2471-8.
8. Hunter DJ, Li J, LaValley M, Bauer DC, Nevitt M, DeGroot J, et al. Cartilage markers and their association with cartilage loss on magnetic resonance imaging in knee osteoarthritis: the Boston Osteoarthritis Knee Study. Arthritis Res Ther. 2007;9:R108.
9. Dam EB, Loog M, Christiansen C, Byrjalsen I, Folkesson J, Nielsen M, et al. Identification of progressors in osteoarthritis by combining biochemical and MRI-based markers. Arthritis Res Ther. 2009;11:R115.
10. Valdes AM, Meulenbelt I, Chassaing E, Arden NK, Bierma-Zeinstra S, Hart D, et al. Large scale meta-analysis of urinary C-terminal telopeptide, serum cartilage oligomeric protein and matrix metalloprotease degraded type II collagen and their role in prevalence, incidence and progression of osteoarthritis. Osteoarthritis Cartilage. 2014;22:683-9.
11. Goldring MB, Otero M. Inflammation in osteoarthritis. Curr Opin Rheumatol. 2011;23:471-8.
12. Kerkhof HJM, Bierma-Zeinstra SMA, Castano-Betancourt MC, de Maat MP, Hofman A, Pols HAP, et al. Serum C reactive protein levels and genetic variation in the CRP gene are not associated with the prevalence, incidence or progression of osteoarthritis independent of body mass index. Ann Rheum Dis. 2010;69:1976-82.
13. Bonnet CS, Walsh DA. Osteoarthritis, angiogenesis and inflammation. Rheumatology (Oxford). 2005;44:7-16.
14. Jin X, Beguerie JR, Zhang W, Blizzard L, Otahal P, Jones G, et al. Circulating C reactive protein in osteoarthritis: a systematic review and meta-analysis. Ann Rheum Dis. 2015;74:703-10.
15. Siebuhr AS, Petersen KK, Arendt-Nielsen L, Egsgaard LL, Eskehave T, Christiansen C, et al. Identification and characterisation of osteoarthritis patients with inflammation derived tissue turnover. Osteoarthritis Cartilage. 2014;22:44-50.
16. Skjøt-Arkil H, Schett G, Zhang C, Larsen DV, Wang Y, Zheng Q, et al. Investigation of two novel biochemical markers of inflammation, matrix metalloproteinase and cathepsin generated fragments of C-reactive protein, in patients with ankylosing spondylitis. Clin Exp Rheumatol. 2011;30:371-9.
17. Leeming DJ, He Y, Veidal SS, Nguyen QHT, Larsen DV, Koizumi M, et al. A novel marker for assessment of liver matrix remodeling: An enzyme-linked immunosorbent assay (ELISA) detecting a MMP generated type I collagen neo-epitope (C1M). Biomarkers. 2011;16:616-28.
18. Siebuhr AS, Bay-Jensen AC, Leeming DJ, Plat A, Byrjalsen I, Christiansen C, et al. Serological identification of fast progressors of structural damage with rheumatoid arthritis. Arthritis Res Ther. 2013;15:R86.
19. Attur M, Belitskaya-Lévy I, Oh C, Krasnokutsky S, Greenberg J, Samuels J, et al. Increased interleukin-1β gene expression in peripheral blood leukocytes is associated with increased pain and predicts risk for progression of symptomatic knee osteoarthritis. Arthritis Rheum. 2011;63:1908-17.
20. Attur M, Statnikov A, Samuels J, Krasnokutsky S, Greenberg JD, Li Z, et al. Interleukin-1 receptor antagonist (IL-1Ra) plasma levels predict radiographic progression of symptomatic knee osteoarthritis over 24 months [abstract]. Arthritis Rheum. 2013;65 Suppl 10:804.
21. Hofman A, Brusselle GO, Murad S, van Duijn C, Franco O, Goedegebure A, et al. The Rotterdam Study: 2016 objectives and design update. Eur J Epidemiol. 2015;30:661-708.
22. Kellgren JH, Lawrence JS. Radiological assessment of osteo-arthrosis. Ann Rheum Dis. 1957;16:494-502.
23. Kellgren JH, Jeffrey MR, Ball J. The epidemiology of chronic rheumatism. Atlas of standard radiographs of arthritis. Oxford: Blackwell Scientific Publications; 1963.
24. Reijman M, Hazes JMW, Koes BW, Verhagen AP, Bierma-Zeinstra SMA. Validity, reliability, and applicability of seven definitions of hip osteoarthritis used in epidemiological studies: a systematic appraisal. Ann Rheum Dis. 2004;63:226-32.
25. Schiphof D, Boers M, Bierma-Zeinstra SM. Differences in descriptions of Kellgren and Lawrence grades of knee osteoarthritis. Ann Rheum Dis. 2008;67:1034-6.
26. Kardys I, de Maat MP, Uitterlinden AG, Hofman A, Witteman JCM. C-reactive protein gene haplotypes and risk of coronary heart disease: the Rotterdam Study. Eur Heart J. 2006;27:1331-7.
27. Lubin JH, Colt JS, Camann D, Davis S, Cerhan JR, Severson RK, et al. Epidemiologic evaluation of measurement data in the presence of detection limits. Environ Health Perspect. 2004;112:1691-6.
28. King KB, Lindsey CT, Dunn TC, Ries MD, Steinbach LS, Majumdar S. A study of the relationship between molecular biomarkers of joint degeneration and the magnetic resonance-measured characteristics of cartilage in 16 symptomatic knees. Magn Reson Imaging. 2004;22:1117-23.
29. Wislowska M, Jablonska B. Serum cartilage oligomeric matrix protein (COMP) in rheumatoid arthritis and knee osteoarthritis. Clin Rheumatol. 2005;24:278-84.
30. Sowers M, Karvonen-Gutierrez CA, Yosef M, Jannausch M, Jiang Y, Garnero P, et al. Longitudinal changes of serum COMP and urinary CTX-II predict X-ray defined knee osteoarthritis severity and stiffness in women. Osteoarthritis Cartilage. 2009;17:1609-14.
31. Van Spil WE, DeGroot J, Lems WF, Oostveen JCM, Lafeber F. Serum and urinary biochemical markers for knee and hip-osteoarthritis: a systematic review applying the consensus BIPED criteria. Osteoarthritis Cartilage. 2010;18:605-12.
32. Felson DT. The current and future status of biomarkers in osteoarthritis. J Rheumatol. 2014;41:834-6.
33. Lotz M, Martel-Pelletier J, Christiansen C, et al. Value of biomarkers in osteoarthritis: current status and perspectives. Ann Rheum Dis. 2013;72:1756-63.
34. Kerkhof HJM, Bierma-Zeinstra SMA, Arden NK, Metrustry S, Castano-Betancourt M, Hart DJ, et al. Prediction model for knee osteoarthritis incidence, including clinical, genetic and biochemical risk factors. Ann Rheum Dis. 2014;73:2116-21.
35. Dieppe PA, Lohmander LS. Pathogenesis and management of pain in osteoarthritis. Lancet. 2005;365:965-73.
36. Felson DT. The sources of pain in knee osteoarthritis. Curr Opin Rheumatol. 2005;17:624-8.
37. Schiphof D, Kerkhof HJM, Damen J, de Klerk BM, Hofman A, Koes BW, et al. Factors for pain in patients with different grades of knee osteoarthritis. Arthritis Care Res. 2013;65:695-702.
38. Arendt-Nielsen L, Eskehave TN, Egsgaard LL, Petersen KK, Graven-Nielsen T, Hoeck HC, et al. Association between experimental pain biomarkers and serological markers in patients with different degree of painful knee osteoarthritis. Arthritis Rheumatol. 2014;66:3317-26.
39. Kraus VB, Kepler TB, Stabler T, Renner J, Jordan J. First qualification study of serum biomarkers as indicators of total body burden of osteoarthritis. PLoS One. 2010;5:e9739.
40. Mazzuca SA, Brandt KD, Dieppe PA, Doherty M, Katz BP, Lane KA. Effect of alignment of the medial tibial plateau and x-ray beam on apparent progression of osteoarthritis in the standing anteroposterior knee radiograph. Arthritis Rheum. 2001;44:1786-94.
41. Felson DT, Nevitt MC. Epidemiologic studies for osteoarthritis: new versus conventional study design approaches. Rheum Dis Clin North Am. 2004;30(4):783-97.